Unilever’s McCormick tie-up gets saucy with CMA probe
Unilever and McCormick plan to defend their $65bn merger, proposing the sale of Colman's Mustard to address CMA concerns about market dominance in UK sauces and ingredients. The CMA warned the merger could reduce competition, but Unilever argues the sale is sufficient. Both companies' shares dropped after the deal was announced.
How this was made

The 30-second read
Why it matters
The regulatory hurdle adds uncertainty to the transaction, likely weighing on both companies' share prices until the CMA’s final decision.
Market read
Regulatory review of a mega‑merger between two large consumer‑goods firms creates short‑term downside risk for both stocks and may influence broader sector M&A sentiment.
What to watch
Potential alternative buyers for Colman's or other assets could mitigate regulator concerns and preserve deal value.
Background
Unilever announced a $65bn merger with McCormick in March, prompting a CMA investigation into competition in the UK sauce and ingredient market. The regulator now requires undertakings, such as selling Colman's Mustard, to proceed.
Ticker impact
Unilever faces a CMA probe over its $65bn food tie‑up with McCormick and plans to sell Colman's Mustard to address competition concerns.
likely downside as investors price in potential deal blockage or additional divestitures
CMA has escalated its investigation and may require further undertakings; large‑cap deals under regulator review typically see share‑price weakness.
McCormick is the New York‑listed partner in the Unilever food merger that is under CMA investigation, with the regulator demanding undertakings.
likely downside as market assesses risk of deal delay or additional conditions
Regulatory hurdles for a high‑profile cross‑border acquisition often translate into short‑term share‑price pressure for both parties.
Market effects
Food and consumer‑staples sector may see heightened scrutiny on consolidation, potentially slowing M&A activity.
UK market could react to regulator’s stance, affecting other consumer‑goods firms with pending deals.
The deal’s size makes it a headline for global investors tracking large‑cap M&A and competition policy.
Counterpoint
If the CMA grants a swift approval after the Colman's divestiture, the merger could unlock synergies and boost both stocks.
Key entities
- CompanyUnilever
FTSE 100 consumer‑staples giant, merger partner.
- CompanyMcCormick
New York‑listed spice and flavor company, merger partner.
- RegulatorCMA
UK Competition and Markets Authority reviewing the deal.



